What is the difference between a point mutation and a frameshift mutation?

On boards, a point mutation is a single-base substitution. It can be silent, missense or nonsense, and it changes at most one codon. A frameshift is an insertion or deletion whose length is not a multiple of 3, so every codon downstream is read in the wrong frame, usually producing a premature stop and a nonfunctional protein. A single-base deletion is therefore a frameshift, not a substitution.

What are examples of splice-site mutations?

β-thalassemia is the classic example: many HBB mutations alter splice junctions or consensus sequences, and those at the junction itself tend to abolish β-globin production. The IVS2-654 allele, common in Chinese and Southeast Asian populations, activates a cryptic splice site so the mRNA keeps 73 nucleotides of intron 2 and the frame shifts. Familial dysautonomia is caused by a splicing mutation in the ELP1 gene.

Why do frameshift deletions cause Duchenne while in-frame deletions cause Becker?

Most dystrophin mutations are deletions of one or more exons. If a deletion shifts the reading frame, translation soon reaches a premature stop and essentially no functional dystrophin is made, causing Duchenne. If the deletion removes a multiple of 3 bases, the frame is preserved and a shorter, partly functional dystrophin causes the milder Becker dystrophy. This reading-frame rule holds in about 90% of patients.

Is cystic fibrosis F508del a frameshift mutation?

No. F508del removes a single amino acid, phenylalanine at position 508, which means three nucleotides are deleted and the reading frame is preserved, so it is an in-frame deletion. The abnormal CFTR channel is broken down shortly after it is made and never reaches the cell membrane, which is why the mutation causes disease even though the rest of the protein sequence is intact.

What is nonsense-mediated decay?

Nonsense-mediated decay is the destruction of an mRNA that carries a premature stop codon, which prevents truncated proteins from accumulating. In β-thalassemia, premature stops in exons 1 or 2 of the β-globin gene trigger it and leave very little mRNA, whereas stops in exon 3 escape decay and produce unstable, truncated chains that cause a dominant form of β-thalassemia.

Point vs Frameshift vs Splice-Site Mutations (USMLE)

A point mutation (on boards, a single-base substitution) is silent if the new codon codes for the same amino acid, missense if it codes for a different one (sickle cell disease: glutamic acid → valine at position 6 of β-globin), and nonsense if it creates a premature stop codon. A frameshift is an insertion or deletion whose length is not a multiple of 3, so every downstream codon is misread (out-of-frame DMD deletions → Duchenne); a deletion of exactly 3 bases is in-frame (cystic fibrosis F508del removes one amino acid). A splice-site mutation breaks the GU…AG borders of an intron, so the mRNA is spliced wrongly (β-thalassemia).

The 10-second mutation sorter (flowchart)

Was one base swapped for another? → Point mutation. Translate the new codon:
- same amino acid → silent (synonymous)
- different amino acid → missense
- stop codon (UAA, UAG or UGA) → nonsense
Were bases inserted or deleted? Count them:
- not a multiple of 3 → frameshift
- a multiple of 3 → in-frame insertion or deletion
Is the change at an exon–intron junction, or does the stem say "abnormal mRNA processing" or "intron retained"? → splice-site mutation
Did a short repeated sequence get longer? → repeat expansion, the mechanism behind the trinucleotide repeat disorders
Predict the protein: silent usually changes nothing; missense changes one residue (loss or gain of function); nonsense and frameshift usually truncate the protein; splice-site errors put the wrong sequence into the mRNA.

Mutation types at a glance

Type	DNA change	Effect on the protein	Classic example
Silent	Substitution; codon still codes for the same amino acid	Usually none	No classic disease; "silent" is not always harmless
Missense	Substitution; codon codes for a different amino acid	One residue changed; loss or gain of function	Sickle cell (Glu6Val), HbC (Glu6Lys), achondroplasia (FGFR3 glycine → arginine)
Nonsense	Substitution creates a stop codon	Shortened protein, often with mRNA degraded	β⁰-thalassemia (codon 39 nonsense); some Duchenne cases
Frameshift	Insertion or deletion not divisible by 3	Downstream codons scrambled; premature stop common	Duchenne muscular dystrophy (out-of-frame deletions)
In-frame indel	Insertion or deletion of 3, 6, 9… bases	Amino acids added or removed; frame preserved	Cystic fibrosis F508del; Becker muscular dystrophy (in-frame deletions)
Splice-site	Change at the splice junctions or consensus sequences	Wrong splice sites used; abnormal mRNA	β-thalassemia; familial dysautonomia (ELP1)
Repeat expansion	A short repeat is copied more times	Protein may function improperly	Trinucleotide repeat disorders

Point mutations: silent, missense, nonsense

Silent. The genetic code has 64 codons: 61 specify amino acids and 3 are stop codons, so many amino acids are encoded by more than one codon. A substitution that swaps one synonymous codon for another leaves the protein unchanged. "Silent" is not always harmless, though, because a coding substitution can also change how the mRNA is spliced. HbE shows the principle: its codon 26 G→A change is a missense (glutamic acid → lysine) that also activates a cryptic splice site in exon 1, which is why HbE behaves like a mild β-thalassemia allele.

Missense. One amino acid changes. In sickle cell disease, valine replaces glutamic acid at position 6 of β-globin, and hemoglobin S molecules stick together into long, rigid polymers that sickle the cell; in HbC, lysine replaces the same glutamic acid. Missense changes can also gain function: two variants that cause more than 99% of achondroplasia both swap glycine for arginine in FGFR3 and make the receptor overactive.

Nonsense. A premature stop codon gives a shortened protein that may be nonfunctional or degraded. Premature stops can also trigger nonsense-mediated decay of the mRNA itself: in β-globin, stops in exons 1 or 2 leave very little mRNA in red cell precursors, whereas stops in exon 3 escape decay and make unstable, truncated chains that cause a dominant form of β-thalassemia.

Frameshift vs in-frame: the reading-frame rule

Ribosomes read mRNA in triplets. Delete one base and every codon after it changes:

Normal: AUG | GCU | UAC | …
One G deleted: AUG | CUU | AC…

Insertions, deletions and duplications can all cause frameshifts, and the resulting protein is usually nonfunctional. Adding or removing whole codons (multiples of 3) keeps the rest of the protein readable.

Duchenne vs Becker is the classic test of this rule. Deletions of one or more exons cause up to 70% of Duchenne cases. Deletions that throw the reading frame off (out-of-frame) produce essentially no functional dystrophin and cause Duchenne; deletions that keep the frame produce a shorter, partly functional dystrophin and cause the milder Becker dystrophy. The rule, proposed by Monaco and colleagues in 1988, holds in about 90% of patients. Exon-skipping antisense drugs such as eteplirsen exploit it: they mask an exon so that it is skipped, aiming for a Becker-like protein. Review the inheritance side in the X-linked disorders flowchart.

Cystic fibrosis F508del is the classic in-frame deletion: it removes a single amino acid (phenylalanine 508). The abnormal channel is broken down shortly after it is made and never reaches the cell membrane.

Splice-site mutations

Introns are cut out at conserved sequences: most introns begin with GU at the 5′ (donor) splice site and end with AG at the 3′ (acceptor) site, written GT…AG in DNA. A branch-point adenine 18–40 nucleotides upstream of the intron's 3′ end forms the lariat, and small nuclear ribonucleoproteins (snRNPs) in the spliceosome catalyze the reaction. Changing one of the conserved nucleotides inhibits normal splicing, so the spliceosome may use a nearby cryptic splice site or leave intron sequence in the mature mRNA. The message is then the wrong length and often out of frame. For the normal steps, see the RNA processing cheat sheet.

β-thalassemia: more than 200 HBB mutations are known, mostly single-nucleotide substitutions or small insertions and deletions. They fall into three groups: transcription (promoter), mRNA processing (splice-junction and consensus-sequence changes, polyadenylation) and translation (nonsense, frameshift, initiation codon). Mutations at the splice junction itself tend to abolish β-chain production (β⁰). Example: IVS2-654 (C→T), common in Chinese and Southeast Asian populations, activates a cryptic splice site, so the mRNA keeps 73 nucleotides of intron 2 and the frame shifts. Compare the thalassemias in the alpha vs beta thalassemia table.
Familial dysautonomia: nearly all affected people carry two copies of the same splicing mutation in ELP1 (formerly IKBKAP), which reduces ELP1 protein, especially in brain cells.
Treatment tie-in: splice-switching antisense oligonucleotides block splicing elements in pre-mRNA to change which splice sites are used; eteplirsen (Duchenne) and nusinersen (spinal muscular atrophy) are FDA-approved examples.

Exam traps

"Point mutation" is ambiguous outside the exam. NHGRI defines it as a single base pair added, deleted or changed, but USMLE uses it for substitutions. A single-base deletion is a frameshift.
Three bases deleted is not a frameshift (F508del).
Nonsense vs frameshift: both end in a premature stop. Classify by the DNA change: a substitution that creates a stop is nonsense; an indel is a frameshift.
Size doesn't decide Duchenne vs Becker; the frame does.
Silent isn't always silent: a coding base change can also alter splicing.
Splice-site vs nonsense: if the stem places the change at an exon–intron boundary or describes abnormally sized mRNA, choose splice-site, even if a stop codon results downstream.
Missense can be gain-of-function (FGFR3 in achondroplasia).

Worked example

Vignette. A 4-year-old boy has trouble climbing stairs and rising from the floor, and his calves are enlarged. Creatine kinase is markedly elevated. Genetic testing shows a deletion of 7 nucleotides within one exon of the DMD gene. Which best describes the mutation and its expected consequence?

Answer: A frameshift deletion: 7 is not a multiple of 3, so every downstream codon is misread and a premature stop codon is likely, leaving essentially no functional dystrophin (Duchenne pattern).

Why the distractors fail:

In-frame deletion: would need a multiple of 3 bases and would predict a shorter, partly functional dystrophin (Becker pattern).
Nonsense mutation: also truncates dystrophin, but it is a single-base substitution, not a deletion.
Missense mutation: one base substituted and one amino acid changed; the frame is untouched.
Splice-site mutation: would sit at the GU…AG exon–intron boundary and change which splice sites are used.

Key takeaways

Substitution: silent (same amino acid), missense (new amino acid), nonsense (stop codon).
Indel not divisible by 3 = frameshift; divisible by 3 = in-frame.
Duchenne (out-of-frame) vs Becker (in-frame): the reading-frame rule.
Splice sites: GU at the donor, AG at the acceptor; mutations cause cryptic splicing or retained intron sequence (β-thalassemia, familial dysautonomia).
Premature stops can trigger nonsense-mediated decay (β-globin stops in exons 1–2).
Classic missense examples: sickle cell (Glu6Val), HbC (Glu6Lys), achondroplasia (FGFR3, gain of function).